Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilize the disease and alleviate symptoms. One such therapy is to treat the patient with their own stem cells. This often involves weeks in hospital. Using machine learning methods, a research team has now assessed the conditions in which some of the therapy can be safely carried out as an outpatient.
This article was originally published on MedicalXpress.com
